We report here that mRNA expression of the mTORC1 substrate and mRNA translational repressor EIF4EBP1 is increased in MBs, as compared to non-neoblastic brain tissue, is higher in Group 3 versus Group 4 MBs, and is associated with patient outcome. This evidence concerns the gene EIF4EBP1 and Mobius syndrome.